These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8646002)

  • 21. The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression.
    Burnett FE; Scott LV; Weaver MG; Medbak SH; Dinan TG
    J Affect Disord; 1999 Jun; 53(3):263-8. PubMed ID: 10404712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid regulation of luteinizing hormone in amenorrheic patients after therapy for induction of ovulation.
    Nappi C; Petraglia F; Di Meo G; Minutolo M; Genazzani AR; Montemagno U
    Fertil Steril; 1987 Apr; 47(4):579-83. PubMed ID: 3032691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of the opioid system in the functional regulation of the hypothalamo-hypophyseal-adrenal system in traumatic shock].
    El'skiĭ VN; Slepushkin VD; Samsonenko RA; Sergeeva LA; Talalaenko VN
    Patol Fiziol Eksp Ter; 1985; (6):15-9. PubMed ID: 3005954
    [No Abstract]   [Full Text] [Related]  

  • 24. Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls.
    Martín del Campo AF; Dowson JH; Herbert J; Paykel ES
    J Affect Disord; 2000; 57(1-3):37-47. PubMed ID: 10708814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effects of the pulsatile administration of naloxone on the secretion of gonadotrophins in a case of hypothalamo-hypophyseal amenorrhea].
    Armani J; Gandar R; Baldauf JJ
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(3):301-3. PubMed ID: 3928739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
    Buyalos RP; Jackson RV; Grice GI; Hockings GI; Torpy DJ; Fox LM; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3219-24. PubMed ID: 9745431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
    Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
    Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea.
    Genazzani AD; Meczekalski B; Podfigurna-Stopa A; Santagni S; Rattighieri E; Ricchieri F; Chierchia E; Simoncini T
    Fertil Steril; 2012 Feb; 97(2):483-8. PubMed ID: 22137494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of intrahepatic cholestasis of pregnancy on the functions of hypothalamic-pituitary-adrenocortical axis and adrenal cortex in normal neonates].
    Zhu P; Tao FB; Jiang XM; Hao JH; Wang YL; Xu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):5-8. PubMed ID: 20113624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report.
    Oswald LM; McCaul M; Choi L; Yang X; Wand GS
    Biol Psychiatry; 2004 Jan; 55(1):102-5. PubMed ID: 14706432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of the Opioid Antagonist Naloxone on Experimentally Induced Craving in Nicotine-Dependent Individuals.
    Krause D; Warnecke M; Schuetz CG; Soyka M; Manz KM; Proebstl L; Kamp F; Chrobok AI; Pogarell O; Koller G
    Eur Addict Res; 2018; 24(5):255-265. PubMed ID: 30423575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose naloxone (1.0 mg/kg): psychological and endocrine effects in normal male subjects pretreated with one milligram of dexamethasone.
    Martín-Del-Campo AF; Cortés-Sotres J; Herrera-Ferrá K; Ulloa-Aguirre A
    Psychoneuroendocrinology; 1998 May; 23(4):413-24. PubMed ID: 9695140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis.
    Reyes A; Luckhaus J; Ferin M
    Endocrinology; 1990 Aug; 127(2):724-9. PubMed ID: 2197080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment.
    Aloisi AM; Buonocore M; Merlo L; Galandra C; Sotgiu A; Bacchella L; Ungaretti M; Demartini L; Bonezzi C
    Psychoneuroendocrinology; 2011 Aug; 36(7):1032-9. PubMed ID: 21256679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal.
    Culpepper-Morgan JA; Kreek MJ
    Metabolism; 1997 Feb; 46(2):130-4. PubMed ID: 9030816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine.
    Facchinetti F; Martignoni E; Fioroni L; Sances G; Genazzani AR
    Cephalalgia; 1990 Feb; 10(1):51-6. PubMed ID: 2317851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
    Lizcano F; Salvador J
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.